You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
WASHINGTON, DC – Health regulators from the US Food and Drug Administration yesterday defended their decision to crack down on bad actors in the lab community making pharmacogenomic tests claims without sufficient evidence.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.